...
search icon
dna-img

Ginkgo Bioworks Holdings Share Price

DNA
NYQ
$9.09
+$0.09
(1%)
1D
Industry: Biotechnology Sector: Health Care

Ginkgo Bioworks Holdings Analyst Forecast

Ginkgo Bioworks Holdings Share Price Chart

Ginkgo Bioworks Holdings Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$545.31M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
370.99K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.56
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$5 L
$17.58 H
$9.09

About Ginkgo Bioworks Holdings, Common Stock

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. more

Industry: BiotechnologySector: Health Care

Ginkgo Bioworks Holdings Stock Returns

Time FrameDNASectorS&P500
1-Week Return-2.49%1.31%-1.33%
1-Month Return-0.33%1.27%0.78%
3-Month Return15.68%3.74%2.61%
6-Month Return-34.78%15.81%6.19%
1-Year Return-34.64%8.89%11.68%
3-Year Return-87.07%19.23%67.81%
5-Year Return-97.78%35.04%74.06%

Ginkgo Bioworks Holdings Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue76.66M313.84M477.71M251.46M227.04M[{"date":"2020-12-31","value":16.05,"profit":true},{"date":"2021-12-31","value":65.7,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":52.64,"profit":true},{"date":"2024-12-31","value":47.53,"profit":true}]
Cost of Revenue15.61M129.69M204.22M54.01M38.55M[{"date":"2020-12-31","value":7.64,"profit":true},{"date":"2021-12-31","value":63.51,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":26.45,"profit":true},{"date":"2024-12-31","value":18.88,"profit":true}]
Gross Profit61.05M184.15M273.49M197.45M188.49M[{"date":"2020-12-31","value":22.32,"profit":true},{"date":"2021-12-31","value":67.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":72.2,"profit":true},{"date":"2024-12-31","value":68.92,"profit":true}]
Gross Margin79.64%58.68%57.25%78.52%83.02%[{"date":"2020-12-31","value":95.92,"profit":true},{"date":"2021-12-31","value":70.68,"profit":true},{"date":"2022-12-31","value":68.96,"profit":true},{"date":"2023-12-31","value":94.58,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses198.07M2.01B2.48B1.06B748.25M[{"date":"2020-12-31","value":7.98,"profit":true},{"date":"2021-12-31","value":81.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":42.77,"profit":true},{"date":"2024-12-31","value":30.14,"profit":true}]
Operating Income(137.03M)(1.83B)(2.21B)(864.41M)(559.76M)[{"date":"2020-12-31","value":-13702700000,"profit":false},{"date":"2021-12-31","value":-182846700000,"profit":false},{"date":"2022-12-31","value":-220895200000,"profit":false},{"date":"2023-12-31","value":-86440600000,"profit":false},{"date":"2024-12-31","value":-55975700000,"profit":false}]
Total Non-Operating Income/Expense12.39M(11.19M)107.71M26.71M50.77M[{"date":"2020-12-31","value":11.5,"profit":true},{"date":"2021-12-31","value":-10.39,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":24.8,"profit":true},{"date":"2024-12-31","value":47.13,"profit":true}]
Pre-Tax Income(124.83M)(1.84B)(2.12B)(892.94M)(547.51M)[{"date":"2020-12-31","value":-12483400000,"profit":false},{"date":"2021-12-31","value":-183812200000,"profit":false},{"date":"2022-12-31","value":-212139900000,"profit":false},{"date":"2023-12-31","value":-89294000000,"profit":false},{"date":"2024-12-31","value":-54750800000,"profit":false}]
Income Taxes1.89M(1.48M)(15.03M)(71.00K)(479.00K)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-78.35,"profit":false},{"date":"2022-12-31","value":-795.5,"profit":false},{"date":"2023-12-31","value":-3.76,"profit":false},{"date":"2024-12-31","value":-25.36,"profit":false}]
Income After Taxes(126.72M)(1.84B)(2.11B)(892.87M)(547.03M)[{"date":"2020-12-31","value":-12672300000,"profit":false},{"date":"2021-12-31","value":-183664200000,"profit":false},{"date":"2022-12-31","value":-210637200000,"profit":false},{"date":"2023-12-31","value":-89286900000,"profit":false},{"date":"2024-12-31","value":-54702900000,"profit":false}]
Income From Continuous Operations(126.72M)(1.84B)(2.11B)(854.25M)(547.03M)[{"date":"2020-12-31","value":-12672300000,"profit":false},{"date":"2021-12-31","value":-183664200000,"profit":false},{"date":"2022-12-31","value":-210637200000,"profit":false},{"date":"2023-12-31","value":-85425300000,"profit":false},{"date":"2024-12-31","value":-54702900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(126.61M)(1.83B)(2.10B)(892.87M)(547.03M)[{"date":"2020-12-31","value":-12660900000,"profit":false},{"date":"2021-12-31","value":-183004700000,"profit":false},{"date":"2022-12-31","value":-210492900000,"profit":false},{"date":"2023-12-31","value":-89286900000,"profit":false},{"date":"2024-12-31","value":-54702900000,"profit":false}]
EPS (Diluted)-(1.52)(1.23)(0.47)(3.27)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-152,"profit":false},{"date":"2022-12-31","value":-123,"profit":false},{"date":"2023-12-31","value":-47,"profit":false},{"date":"2024-12-31","value":-327,"profit":false}]

Ginkgo Bioworks Holdings Ratios

Ginkgo Bioworks Holdings Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

DNA
Cash Ratio 4.01
Current Ratio 4.39

Ginkgo Bioworks Holdings Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DNA
ROA (LTM) -15.55%
ROE (LTM) -50.02%

Ginkgo Bioworks Holdings Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

DNA
Debt Ratio Lower is generally better. Negative is bad. 0.53
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.47

Ginkgo Bioworks Holdings Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DNA
Trailing PE NM
Forward PE NM
P/S (TTM) 3.12
P/B 1.01
Price/FCF NM
EV/R 2.90
EV/Ebitda NM

FAQs

What is Ginkgo Bioworks Holdings share price today?

Ginkgo Bioworks Holdings (DNA) share price today is $9.09

Can Indians buy Ginkgo Bioworks Holdings shares?

Yes, Indians can buy shares of Ginkgo Bioworks Holdings (DNA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DNA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Ginkgo Bioworks Holdings be purchased?

Yes, you can purchase fractional shares of Ginkgo Bioworks Holdings (DNA) via the Vested app. You can start investing in Ginkgo Bioworks Holdings (DNA) with a minimum investment of $1.

How to invest in Ginkgo Bioworks Holdings shares from India?

You can invest in shares of Ginkgo Bioworks Holdings (DNA) via Vested in three simple steps:

  • Click on Sign Up or Invest in DNA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Ginkgo Bioworks Holdings shares
What is Ginkgo Bioworks Holdings 52-week high and low stock price?

The 52-week high price of Ginkgo Bioworks Holdings (DNA) is $17.58. The 52-week low price of Ginkgo Bioworks Holdings (DNA) is $5.

What is Ginkgo Bioworks Holdings price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Ginkgo Bioworks Holdings (DNA) is

What is Ginkgo Bioworks Holdings price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Ginkgo Bioworks Holdings (DNA) is 1.01

What is Ginkgo Bioworks Holdings dividend yield?

The dividend yield of Ginkgo Bioworks Holdings (DNA) is 0.00%

What is the Market Cap of Ginkgo Bioworks Holdings?

The market capitalization of Ginkgo Bioworks Holdings (DNA) is $545.31M

What is Ginkgo Bioworks Holdings's stock symbol?

The stock symbol (or ticker) of Ginkgo Bioworks Holdings is DNA

How Can Investors Use Ginkgo Bioworks Holdings Share Price Data for Long-Term Investment Decisions?

Consider the share price of Ginkgo Bioworks Holdings as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Ginkgo Bioworks Holdings has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Ginkgo Bioworks Holdings shares for Indian investors?

When investing in Ginkgo Bioworks Holdings shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Ginkgo Bioworks Holdings stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Ginkgo Bioworks Holdings share price with other stocks in the same sector?

Rather than merely checking the share price of Ginkgo Bioworks Holdings and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Ginkgo Bioworks Holdings stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top